Post-approval studies (Phase 4)Study completedNCT01732367
What this trial is testing
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA
Who this might be right for
Chronic Hepatitis B
Keimyung University Dongsan Medical Center 171